Goodman Advisory Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10
Closed -$482 155
2026
Q1
$482 Hold
10
﹤0.01% 182
2025
Q4
$485 Hold
10
﹤0.01% 181
2025
Q3
$472 Hold
10
﹤0.01% 181
2025
Q2
$483 Hold
10
﹤0.01% 144
2025
Q1
$555 Buy
+10
New +$541 ﹤0.01% 176
2024
Q4
Sell
-10
Closed -$576 157
2024
Q3
$576 Hold
10
﹤0.01% 192
2024
Q2
$485 Hold
10
﹤0.01% 173
2024
Q1
$486 Hold
10
﹤0.01% 168
2023
Q4
$497 Hold
10
﹤0.01% 148
2023
Q3
$536 Hold
10
﹤0.01% 153
2023
Q2
$539 Hold
10
﹤0.01% 151
2023
Q1
$544 Hold
10
﹤0.01% 154
2022
Q4
$0 Hold
10
﹤0.01% 160
2022
Q3
$0 Hold
10
﹤0.01% 175
2022
Q2
$1K Buy
+10
New +$531 ﹤0.01% 166

Other funds holding SNY

Goodman Advisory Group's SNY Position: Q2 2026 in Review

Goodman Advisory Group sold out of Sanofi (SNY) in Q2 2026, closing a stake of 10 shares — an estimated $482 sold.

Goodman Advisory Group first reported a position in SNY in Q2 2022 and held it in 15 quarters. The position peaked at $1K in Q2 2022. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Goodman Advisory Group reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
  • Goodman Advisory Group sold 10 Sanofi shares in Q2 2026, an estimated $482.
  • Goodman Advisory Group first reported a position in Sanofi in Q2 2022 and held it in 15 quarters.
  • Goodman Advisory Group's Sanofi position peaked at $1K in Q2 2022.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Goodman Advisory Group's 13F filing for Q2 2026, filed 12 Aug 2026.